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Abstract .  The sonographic findings in the b ladder  are 
presented in four children with myelomeningocele  and 
neurogenic  dysfunction of the bladder,  who were t reated 
with intermittent self-catheterization and intravesical 
oxybutinin chloride. All were referred for routine sonogra- 
phy of the urinary tract. Each had infused a crushed tablet 
of oxybutinin chloride intravesically 30-120 min before the 
examination. In two children, brightly echogenic, non-sha- 
dowing particles were suspended in the bladder urine. In 
one of these, the particles swirled giving the impression of a 
"snowstorm"; in the other, most of the particles gradually 
settled forming an irregular clump on the bladder base. In 
the remaining two children, the urine appeared diffusely 
hazy with innumerable tiny particles giving the impression 
of a fine mist filling the bladder. The sonographic appear- 
ance of the urine in the bladder after intravesical instilla- 
tion of crushed tablets can be dramatic and can simulate 
pus, blood, fungus, or other debris in the bladder lumen. In 
the absence of clinical symptoms or hematuria, a history of 
recent infusion of medication into the bladder should be 
sought. 
nography (at age 6 years), innumerable brightly echogenic non-sha- 
dowing i to 2-mm particles were visible suspended within the blad- 
der urine. (Fig. 1) The particles swirled, giving the impression of a 
"snowstorm". Approximately 1 h earlier his mother had crushed a 
5-mg tablet of oxybutinin chloride against her kitchen counter with 
a spoon. She scooped the crushed tablet into a syringe containing 
gentamicin solution and infused it into his bladder through the ca- 
theter. The boy was asymptomatic and urinalysis showed only occa- 
sional red and white blood cells and a few bacteria. 
Case 2 
A girl with a lumbar myelomeningocele and neurogenic dysfunc- 
tion of the bladder had been treated with ISC. At 5 years of age she 
was put on a regimen of intravesical oxybutinin chloride (5 mg 
t. i. d.). On two successive ultrasound examinations the bladder was 
filled with non-shadowing, echogenic particulate material. On one 
sonogram (at age 6.5 years) innumerable tiny particles were seen 
The sonographic findings in the b ladder  are presented in 
four children with myelomeningoce le  and neurogenic  
dysfunction of the b ladder  who were  being t rea ted  with 
intermit tent  self-catheterization (ISC) and intravesical 
oxybutinin chloride (Ditropan,  Mar ion Laborator ies ,  
Kansas  City, Mo). 
Case reports 
Case 1 
A boy with a lumbosacral lipomyelomeningocele and neurogenic 
dysfunction of the bladder had been treated with ISC and daily gen- 
tamicin irrigation of his bladder. At 5 years of age, intravesical oxy- 
butinin chloride (2.5 mg b. i. d.) was prescribed. During routine so- 
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Fig.1. US of bladder, longitudinal view, in a 6-year-old boy with 
neurogenic dysfunction due to myelomeningocele (case 1). Ap- 
proximately i h earlier his mother had infused a crushed 5 mg tab- 
let of oxybutinin chloride into his bladder. Innumerable brightly 
echogenic, non-shadowing 1-2 mm particles are suspended in the 




A girl had a low lumbar myelomeningocele and hydromyelia with a 
lumbar intraspinal dermoid that had been repaired in infancy. At 
4 years of age she was put on a regimen of intravesical oxybutinin 
chloride (5 mg b. i. d.). During routine sonography at 6 years of age 
innumerable tiny non-shadowing echogenic particles were visible 
suspended within the urine in her bladder, producing a hazy appear- 
ance. With the patient supine, the particles appeared to slowly settle 
into a clump on the bladder base. She was asymptomatic and urina- 
lysis was negative. Two hours earlier she had received an intravesi- 
cal dose of oxybutinin chloride. Her mother had used a commercial 
pill crusher to grind a 5-mg tablet of oxybutinin chloride to a pow- 
dery consistency and then mixed the powdered medication in a gen- 
tamicin solution and waited approximately 2 min before infusing 
the suspension into the child's bladder. 
Fig.2. US of the bladder, longitudinal view, in a 6.5-year-old girl 
with neurogenic dysfunction due to myelomeningocele (case 2). 
Just before the examination her mother had infused oxybutinin 
chloride into her bladder. Innumerable tiny particles are sus- 
pended in the urine in the bladder resulting in a misty appearance 
with the largest particles settling along the bladder base 
suspended in the urine in the bladder, resulting in a misty appear= 
ance with the largest particles settling along the bIadder base. 
(Fig.2) On the other sonogram (at age 7 years), numerous larger 
echogenic fragments (1-2 mm in diameter) were seen. The g~rl was 
asymptomatic at the time of both studies. The two sonographic ap- 
pearances corresponded to two different methods that the .pa- 
tient's mother had used for crushing the oxybutinin tablets, She 
usually prepared an 8-day supply in advance by filling eight 30-ml 
containers with gentamicin solution and adding a crushed 5-rag tab- 
let to each vial, refrigerating them until use. Just before infusing the 
medication into her child's bladder, she shook the vial several times 
producing a suspension of very fine particles. Alternatively, when 
she ran out of her pre-made supply, she crushed a 5-mg tablet of 
oxybutinin chloride between two spoons and added the fragments 
to a syringe containing the gentamicin solution that she then in- 
fused into the child's bladder. 
Case 4 
A boy was born with a lumbosacral myelomeningocele that was re- 
paired when he was 2 days old. At 4 years of age, intravesical oxybu- 
tinin chloride (5 mg t. i. d.) was prescribed. During routine follow-up 
sonography at 6 years of age, the urine in his bladder appeared dif- 
fusely cloudy like a fine mist filling the bladder. Several hours be- 
fore the examination his mother had given him an intravesical dose 
of oxybutinin chloride. She prepared the medication by crushing a 
5-mg tablet between two spoons and then added the crushed tablet 
to a syringe containing a gentamicin solution. The chiId was asymp- 
tomatic, and urinalysis was normal apart from showing occasional 
white blood cells. 
Discussion 
O x y b u t i n i n  chlor ide  is f r equen t ly  used for t rea t ing  chil- 
d r en  with m y e l o m e n i n g o c e l e  and  n e u r o g e n i c  dysfunc-  
t ion  of the b l adde r  [1-5]. The  m e c h a n i s m  of ac t ion  of 
o x y b u t i n i n  is t h rough  a direct  an t i spasmodic  effect on  
the de t rusor  muscle ,  a nd  inh ib i t i on  of the musca r in i c  ac- 
t ion  of ace ty lchol ine  on  smoo th  muscle .  The  resul t  is a 
lower ing  of the  in t raves ica l  fi l l ing pressure.  
W h e n  a d m i n i s t e r e d  orally, o x y b u t i n i n  is usual ly  very  
effective, a l though  va r i a t ion  in  the rate  of its abso rp t ion  
ma y  reduce  its effect iveness  [4]. An t i cho l ine rg i c  side ef- 
Table 1. Visual appearances of suspensions of tablets of oxybutinin chloride in sterile water using different methods of fragmenting the tablet 
Time Whole tablet Tablet split in half Tablet crushed between spoons Tablet pounded on wax paper 
0 min Whole tablet unchanged Two halves of tablet Multiple particles of non-uniform Multiple very fine particles 
unchanged size settled on bottom suspended with larger 
Some fine particles 
particles settled on bottom 
Some fine particles suspended 
with dusting on bottom; some 
suspended particles clumping 
5 min Some fine particles 
suspended with tablet still suspended with dusting on 
identified bottom; larger particles 
settled on bottom 
15 min Some fine particles Uniform fine particles with No further change Non-uniform fine particles 
suspended with dusting on dusting on bottom; fine suspended with dusting on 
bottom; small particles particles floating on surface bottom; small particles 
floating on surface and and clinging to sides of floating on surface and 
clinging to sides of container container clinging to sides 
30 min No further change No further change No further change No further change 
Some fine particles suspended 
with dusting on bottom; some 
suspended particles clumping 
One 5 mg tablet of oxybutinin chloride was suspended in 10 ml of tap water at room temperature in a 30-ml vial in each experiment. Each sus- 
pension was agitated for 3 s at 0, 5, 15, and 30 min 
350 
the patient (or the patient 's parent)  for crushing the ta- 
blets (Table 1). When the tablets are broken into larger 
pieces, brightly echogenic, non-shadowing particles of 
varying sizes are seen suspended in the bladder urine 
(Fig. 1). The particles can swirl, giving the impression of 
a "snowstorm",  or can gradually settle to form an irregu- 
lar clump on the bladder base. When the tablets are pul- 
verized, the urine appears diffusely hazy with innumer- 
able tiny particles, giving the impression of a fine mist fill- 
ing the bladder (Fig. 2). Although some of the medicat ion 
may become dissolved in urine, much is actually sus- 
pended rather  than dissolved. When tablets of oxybuti- 
nin chloride are suspended in water, a large amount  of 
particulate material can be demonstra ted sonographi- 
cally (Table 1, Fig. 3). 
To our knowledge there have been no previous re- 
ports of the sonographic appearance of the urine in the 
bladders of children who have been t reated with intrave- 
sical medications. The appearance of suspended oxybuti- 
nin particles can be dramatic and can simulate pus [6-7], 
blood, fungus [8], or other  debris in the bladder lumen. 
When echogenic debris is visible in the bladder of a child 
who is on ISC, and there are no clinical symptoms of 
acute urinary infection or hematuria,  a history of recent  
infusion of medication into the bladder should be sought. 
Fig. 3 a, b. Sonographic appearance of sterile water before and after 
suspension of a crushed tablet of oxybutinin chloride, a Sterile 
water; b sterile water 5 rain after introduction of crushed tablet 
fects are also very common (in 40-80 % of cases), and fre- 
quently prompt  either decreased dosing or discontinua- 
tion of the medicat ion altogether [5]. Oxybutinin may 
be administered intravesically in children on ISC for 
whom the drug has not proved to be acceptable when 
given orally [1, 2, 4]. Intravesical oxybutinin is clinically 
effective and is associated with fewer side effects. A spe- 
cific formulat ion of oxybutinin designed for intravesical 
use does not exist. Liquid preparations of oxybutinin are 
not used intravesically because they contain glucose and 
may promote  bacterial growth [2]. Therefore,  most par- 
ents are instructed to suspend crushed oxybutinin tab- 
lets in saline for instillation into their child's bladder. 
Alterations in the sonographic appearance of the 
urine in the bladder have been observed after intravesi- 
cal instillation of crushed tablets. Differences in the ap- 
pearance probably depend upon the size and number  of 
the particles, and may correspond to the method  used by 
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